Trial
NCT04109092
A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Eisai Inc.
Collaborators
H3 Biomedicine Inc.
Condition
Urinary Bladder Neoplasms
Intervention
E7766
Why stopped
There was no enrolment of participants.Unscheduled Clinical Study Closure - Eisai Network Company Decision, November 12, 2020.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-12-14